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Abstract The research aims are to study the role of CYP1A1
gene polymorphism in predisposition to erysipelas and reveal
connections with the clinical course of the disease. We used
the standard techniques of molecular genetic analysis. The
DNA samples used in genotyping were extracted from leuko-
cytes of venous blood by deproteinization with a phenol-
chloroform mixture. Genotyping was performed by polymer-
ase chain reaction (PCR). Statistical data relating to the inves-
tigated polymorphic markers were estimated at a 95% confi-
dence level (CL). Genotype frequencies were compared using
either the standard Pearson’s chi-squared test or the two-sided
Fisher’s exact test. This study presents a comparative analysis
of the distribution of gene polymorphisms of cytochrome
P450 CYP1A1 (Ile462Val, rs1048943) of phase I detoxifica-
tion (microsomal oxidation) in the experimental group of 71
patients with erysipelas and a control group of 71 healthy
individuals. We also analyzed these relationships of
CYP1A1 (Ile462Val) gene polymorphisms with the sex of
the patients, the severity and multiplicity of the disease, and
the nature of the local process in patients with erysipelas. The
results of the investigation indicate the presence of a relation-
ship between cytochrome P450 CYP1A1 (Ile462Val,
rs1048943) gene polymorphism and the development of ery-
sipelas. Analysis of these relationships of CYP1A1
(Ile462Val) gene polymorphism with the sex of the patients,
the severity and multiplicity of the disease, and the nature of
the process in the examined group of patients with erysipelas
did not reveal any statistically significant differences.
Keywords Erysipelas . CYP1A1 gene . Polymorphism
1 Introduction
The incidence rate of erysipelas due to Streptococcus
pyogenes remains persistently high. It is the fourth most com-
mon infectious disease and has a considerable social and eco-
nomic impact. The incidence rate of erysipelas (S. erysipelas)
in Russia is 10 to 12 per 10,000 people [1, 2]. There has been
an increase in cases of severe and recurrent forms of the dis-
ease [3].
Many studies have identified frequent background
(comorbid) pathologies in patients with erysipelas. It has been
shown that local factors (dermatophytosis, trophic ulcers, var-
icosities, phlebitis) and general factors (obesity, diabetes, heart
failure) increase the risk of erysipelas [4–6]. Erysipelas devel-
opment, as other multifactorial diseases, is determined by a
complex combination of genetic factors and unfavorable en-
vironmental factors [4, 6, 7]. The wide variability in the clin-
ical course of the disease is characterized by its multiplicity
and the nature of the local process, and suggests the need for
the study of common genetic risk factors for erysipelas and
factors predisposing the development of certain forms of this
disease [4–6, 8, 9]. In that regard, the identification of risk
factors for erysipelas which predict the probability of the dis-
ease, its clinical course, and the development of preventive
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